![](/img/cover-not-exists.png)
Tumor intrinsic efficacy by SHP2 and RTK inhibitors in KRAS mutant cancers
Hao, Huai-Xiang, Wang, Hongyun, Liu, Chen, Kovats, Steven, Velazquez, Roberto, Lu, Hengyu, Pant, Bhavesh, Shirley, Matthew, Meyer, Matthew J, Pu, Minying, Lim, Joanne, Fleming, Michael, Alexander, LeiLanguage:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-19-0170
Date:
August, 2019
File:
PDF, 13.18 MB
english, 2019